0001192482-21-000393.txt : 20210503
0001192482-21-000393.hdr.sgml : 20210503
20210503210526
ACCESSION NUMBER: 0001192482-21-000393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210430
FILED AS OF DATE: 20210503
DATE AS OF CHANGE: 20210503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kompella Uday
CENTRAL INDEX KEY: 0001791821
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36751
FILM NUMBER: 21885547
MAIL ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY, SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocugen, Inc.
CENTRAL INDEX KEY: 0001372299
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY
STREET 2: SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-328-4698
MAIL ADDRESS:
STREET 1: 5 GREAT VALLEY PARKWAY
STREET 2: SUITE 160
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: HISTOGENICS CORP
DATE OF NAME CHANGE: 20060810
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-04-30
0001372299
Ocugen, Inc.
OCGN
0001791821
Kompella Uday
C/O OCUGEN, INC.
263 GREAT VALLEY PARKWAY
MALVERN
PA
19355
1
0
0
0
Common Stock
2021-04-30
4
M
0
20000
0.51
A
620674
D
Common Stock
2021-04-30
4
S
0
20000
11.56
D
600674
D
Common Stock
2021-05-03
4
S
0
25000
14
D
575674
D
Common Stock
2021-05-03
4
S
0
25000
16.02
D
550674
D
Common Stock
479416.0
I
By: Kompella LLC
Option (right to buy)
0.51
2021-04-30
4
M
0
20000
0
D
2030-01-02
Common Stock
20000
34000
D
This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.43 to $11.70. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
24,000 shares under the option are exercisable. The option, initially representing a right to purchase a total of 54,000 shares, vests and becomes exercisable over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates.
/s/ Uday Kompella by Sanjay Subramanian, his attorney-in-fact
2021-05-03